Looking beyond the spin of Big Pharma PR. But encouraging gossip. Come in and confide, you know you want to! “I’ll publish right or wrong. Fools are my theme, let satire be my song.”
Email: jackfriday2011(at)hotmail.co.uk
Thursday, September 29, 2011
Pfizer faces off-patent smoking drug threat - FT.com
Pfizer is facing a threat to its top-selling smoking cessation drug Champix from the Bulgarian company that has long marketed the low-cost off-patent medicine from which it was derived.
2 comments:
it's chanTix, not chamPix
It's called both. Chantix in the US. Champix in the UK and Europe.
Post a Comment